BR0109691A - Dispositivo e método para tratar incontinência urinária em fêmeas - Google Patents

Dispositivo e método para tratar incontinência urinária em fêmeas

Info

Publication number
BR0109691A
BR0109691A BR0109691-5A BR0109691A BR0109691A BR 0109691 A BR0109691 A BR 0109691A BR 0109691 A BR0109691 A BR 0109691A BR 0109691 A BR0109691 A BR 0109691A
Authority
BR
Brazil
Prior art keywords
ring
oxybutynin
females
urinary incontinence
treating urinary
Prior art date
Application number
BR0109691-5A
Other languages
English (en)
Inventor
Anu Mahashabde
Martha Francine Kay
Donald F Koelmell
Original Assignee
Enhance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enhance Pharmaceuticals Inc filed Critical Enhance Pharmaceuticals Inc
Publication of BR0109691A publication Critical patent/BR0109691A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

"DISPOSITIVO E MéTODO PARA TRATAR INCONTINêNCIA URINáRIA EM FêMEAS". é fornecido aqui um novo e útil dispositivo e método para localmente liberar e controladamente libertar oxibutinina na região cervical de uma fêmea. Um dispositivo da invenção compreende um anel compreendendo elastómero de siloxano de dimetila/trifluoropropilmetila. Uma composição farmacêutica compreendendo oxibutinina e um excipiente é localizado dentro de uma cavidade localizada no anel, onde a cavidade vai da superfície do anel para dentro do anel. O anel tem um tamanho suficiente tal que pode ser inserido dentro do canal vaginal de uma fêmea. Uma tampa compreendida é localizada sobre a cavidade na superfície do anel em ordem para conter a composição farmacêutica dentro da cavidade. Quando o anel é inserido dentro do canal vaginal, o elastómero de siloxano de dimetila/trifluoropropilmetila controladamente libera e localmente liberta uma quantidade terapeuticamente eficaz de oxibutinina ao músculo detrusor para tratar a incontinência urinária da fêmea.
BR0109691-5A 2000-03-21 2001-03-21 Dispositivo e método para tratar incontinência urinária em fêmeas BR0109691A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/531,856 US6436428B1 (en) 2000-03-21 2000-03-21 Device and method for treating urinary incontinence in females
PCT/US2001/008978 WO2001070154A1 (en) 2000-03-21 2001-03-21 Device and method for treating urinary incontinence in females

Publications (1)

Publication Number Publication Date
BR0109691A true BR0109691A (pt) 2003-06-10

Family

ID=24119337

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109691-5A BR0109691A (pt) 2000-03-21 2001-03-21 Dispositivo e método para tratar incontinência urinária em fêmeas

Country Status (12)

Country Link
US (2) US6436428B1 (pt)
EP (2) EP2106785B1 (pt)
JP (3) JP5265836B2 (pt)
AT (1) ATE437630T1 (pt)
AU (2) AU2001245901B2 (pt)
BR (1) BR0109691A (pt)
CA (1) CA2403475C (pt)
DE (1) DE60139389D1 (pt)
ES (1) ES2332262T3 (pt)
IL (2) IL151858A0 (pt)
MX (1) MXPA02009358A (pt)
WO (1) WO2001070154A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
MX2013000002A (es) * 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
HUP0401438A3 (en) * 2001-08-31 2008-04-28 Schering Oy Drug delivery system
JP2005513080A (ja) * 2001-12-20 2005-05-12 フェムファーマ， インコーポレイテッド 薬物の膣送達
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
FR2843303B1 (fr) * 2002-08-07 2006-01-21 R & D Pharma Nouvelles compositions pharmaceutiques destinees au traitement de l'incontinence urinaire
US6770025B2 (en) 2002-09-18 2004-08-03 Kimberly-Clark Worldwide, Inc. Molar shaped vaginal incontinence insert
US6676594B1 (en) 2002-09-18 2004-01-13 Kimberly-Clark Worldwide, Inc. C-shaped vaginal incontinence insert
US7263999B2 (en) * 2002-10-30 2007-09-04 Kabushiki Kaisha Kitazato Supply Ring for preventing prolapse of uterus and urinary bladder and ring for preventing prolapse of uterus and rectum
US6808485B2 (en) 2002-12-23 2004-10-26 Kimberly-Clark Worldwide, Inc. Compressible resilient incontinence insert
MXPA05007266A (es) * 2003-01-02 2006-01-17 Femmepharma Holding Co Inc Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno.
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US8007568B2 (en) * 2006-04-12 2011-08-30 Millipore Corporation Filter with memory, communication and pressure sensor
US8613698B2 (en) 2006-07-10 2013-12-24 Mcneil-Ppc, Inc. Resilient device
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
US7717892B2 (en) 2006-07-10 2010-05-18 Mcneil-Ppc, Inc. Method of treating urinary incontinence
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
CN104257450B (zh) 2006-07-10 2017-05-10 第一次质量卫生公司 弹性装置
EP2104489A2 (en) * 2006-12-26 2009-09-30 FemmePharma Holding Company, Inc. Topical administration of danazol
EP2170276B1 (en) * 2007-06-26 2018-08-22 Allergan Pharmaceuticals International Limited Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US20110028922A1 (en) * 2009-07-31 2011-02-03 Kay Dennis M Female External Incontinence Device
US20120053534A1 (en) * 2010-06-22 2012-03-01 Anu Mahashabde Intravaginal devices comprising anticholinergic agents, and methods of making thereof
MX2013002016A (es) * 2010-08-20 2013-03-25 Teva Womens Health Inc Dispositivos intravaginales, metodos de fabricacion y usos de los mismos.
CN103501764A (zh) * 2011-03-03 2014-01-08 阿勒根公司 基于硅酮的眼科制剂
JP2018509389A (ja) * 2015-01-30 2018-04-05 リ・ガリ・ベスローテン・フエンノートシャップＬｉ Ｇａｌｌｉ Ｂ．Ｖ． 膣用薬物送達デバイス
BR112020008231A2 (pt) 2017-10-27 2020-10-27 Renovia, Inc. dispositivos, sistemas e métodos para treinamento dos músculos do assoalho pélvico
CN119952301A (zh) * 2025-04-10 2025-05-09 中国核动力研究设计院 一种远距离激光切割头及其调焦方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286587A (en) 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4402695A (en) 1980-01-21 1983-09-06 Alza Corporation Device for delivering agent in vagina
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
DE69326848T2 (de) 1992-05-13 2000-01-27 Alza Corp Oxybutynin zur transdermalen Verabreichung
US5900250A (en) 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
JP3066515B2 (ja) * 1992-11-11 2000-07-17 久光製薬株式会社 尿失禁治療用経皮投与製剤
ATE246909T1 (de) 1994-03-07 2003-08-15 Theratech Inc Medikament enthaltende, adhesive, zusammenbaubare,transdermale abgabevorrichtung
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US5677346A (en) 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
US5532278A (en) 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5674895A (en) 1995-05-22 1997-10-07 Alza Corporation Dosage form comprising oxybutynin
US5912268A (en) 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US5785991A (en) 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
JP2001502302A (ja) 1996-09-19 2001-02-20 アメリカン・ホーム・プロダクツ・コーポレイション 尿失禁を治療する方法
DE19812413C1 (de) * 1998-03-20 1999-06-10 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend
US6087396A (en) 1998-10-05 2000-07-11 Situs Corporation Oxybutynin formulations and method of use
AU1256399A (en) 1998-10-07 2000-04-26 Alza Corporation Controlled release dosage from comprising oxybutynin
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
CA2573266C (en) * 2004-07-09 2011-11-08 The Population Council, Inc. Sustained release compositions containing progesterone receptor modulators

Also Published As

Publication number Publication date
ES2332262T3 (es) 2010-02-01
JP5265836B2 (ja) 2013-08-14
EP2106785A1 (en) 2009-10-07
WO2001070154A9 (en) 2001-12-20
AU4590101A (en) 2001-10-03
EP2106785B1 (en) 2016-12-07
US20020090390A1 (en) 2002-07-11
JP5675865B2 (ja) 2015-02-25
EP1278494A1 (en) 2003-01-29
IL151858A (en) 2009-12-24
CA2403475C (en) 2011-02-08
HK1053254A1 (en) 2003-10-17
IL151858A0 (en) 2003-04-10
JP5986149B2 (ja) 2016-09-06
CA2403475A1 (en) 2001-09-27
DE60139389D1 (de) 2009-09-10
WO2001070154A1 (en) 2001-09-27
JP2003527404A (ja) 2003-09-16
EP1278494A4 (en) 2005-11-02
JP2014210802A (ja) 2014-11-13
JP2013107895A (ja) 2013-06-06
MXPA02009358A (es) 2003-09-25
AU2001245901B2 (en) 2004-10-07
EP1278494B1 (en) 2009-07-29
US6436428B1 (en) 2002-08-20
ATE437630T1 (de) 2009-08-15

Similar Documents

Publication Publication Date Title
BR0109691A (pt) Dispositivo e método para tratar incontinência urinária em fêmeas
AR031721A1 (es) Un dispositivo para la incontinencia urinaria y un metodo para hacer el mismo
FR2824257B1 (fr) Dispositif intra-vaginal de prevention de l'incontinence urinaire feminine a l'effort
JP2003527404A5 (pt)
CY1108296T1 (el) Σετ χειρουργικων εργαλειων για τη θεραπεια της γυναικειας ακρατειας ουρων
GB2364916B (en) Drug delivery device
WO2002053071A8 (en) Female incontinence control device
DE60141145D1 (pt)
GB2382993B (en) Apparatus and method for treating female urinary incontinence
WO2004026172A3 (en) C-shaped vaginal incontinence insert
IS4506A (is) Innsetningartæki til að koma fyrir innanlegstæki
DK0526566T3 (da) Behandling af erektil dysfunktion
NZ509894A (en) A "T" or "Y" shaped intravaginal device suitable for delivery of pharmaceuticals such as progesterone
BR0014146A (pt) Aparelho e método para anestesiar a região cervical de uma fêmea
WO2007018622A3 (en) Vaginal treatment composition
ATE289184T1 (de) Urininkontinenzvorrichtung
ATE307544T1 (de) Harninkontinenzvorrichtung
NO995008L (no) En transuretral anordning
BR0311248A (pt) Kit de contracepção e/ou de hrt, usos de um éster de etonogestrel de ação prolongada, de um éster de etonogestrel de ação prolongada em conjunto com um éster de andrógeno de ação prolongada e de um éster de etonogestrel de ação prolongada em conjunto com um estrogênio, e, métodos de contracepção e /ou de hrt e de tratamento e/ou de prevenção de um distúrbio ginecológico feminino
GB2384434A (en) Method and apparatus for treating and preventing urinary tract infections
Chen Refinement of McIndoe's vaginal reconstruction with ORFIT “S” vaginal stent
WO2004014360A3 (fr) Compositions pharmaceutiques destinees au traitement de l'incontinence urinaire
Parmer Long-term suppression of hypermenorrhea by progesterone intrauterine contraceptive devices
Paik et al. Long Term Results of Pubovaginal Sling Procedure Based on Anchoring Sites of Suture Material
UA22826A (uk) Спосіб лікування раку сечового міхура

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BARR LABORATORIES, INC. (US)

Free format text: TRANSFERIDO DE: ENHANCE PHARMACEUTICALS, INC.

B25A Requested transfer of rights approved

Owner name: DURAMED PHARMACEUTICALS, INC. (US)

Free format text: TRANSFERIDO DE: BARR LABORATORIES, INC.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B25D Requested change of name of applicant approved

Owner name: TEVA WOMEN'S HEALTH, INC. (US)

B25G Requested change of headquarter approved

Owner name: TEVA WOMEN'S HEALTH, INC. (US)

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61F 13/00 , A01N 37/44 , A61K 9/14

Ipc: A61K 9/00 (2006.01), A61K 31/216 (2006.01), A61M 3

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: TEVA WOMEN'S HEALTH, INC. (US)

B25D Requested change of name of applicant approved

Owner name: TEVA WOMEN'S HEALTH, INC. (US)